How does the predictability of a technology affect enablement requirements?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The predictability of a technology significantly affects enablement requirements in…
Read MoreWhat is the purpose of 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The purpose of 35 U.S.C. 112(a) or pre-AIA 35 U.S.C.…
Read MoreWhat are the key disclosure requirements for a patent application under 35 U.S.C. 112(a)?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Under 35 U.S.C. 112(a), there are three key disclosure requirements…
Read MoreWhy is the incorporation by reference of the “Sequence Listing XML” important for patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The incorporation by reference of the “Sequence Listing XML” is…
Read MoreWhat are the consequences of failing to comply with the disclosure requirements of 35 U.S.C. 112(a)?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Failing to comply with the disclosure requirements of 35 U.S.C.…
Read MoreCan an applicant submit an Information Disclosure Statement (IDS) after a notice of allowance?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Yes, an applicant can submit an Information Disclosure Statement (IDS)…
Read MoreWhat are the requirements for the description in a PCT application?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The description in a PCT application must meet specific requirements…
Read MoreWhat are the requirements for written description in design patents?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The written description requirement for design patents is outlined in…
Read MoreHow do continuation and divisional applications affect design patent disclosure?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Continuation and divisional applications in design patents must adhere to…
Read MoreHow does a continuation-in-part (CIP) application affect benefit claims under 35 U.S.C. 120 for design patents?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. A continuation-in-part (CIP) application can affect benefit claims under 35…
Read More